What is Applied UV Inc?
Applied UV Inc operates at the intersection of advanced engineering and public health, specializing in the development and acquisition of proprietary technologies designed to mitigate pathogen transmission. By focusing on UV-C disinfection and related environmental safety protocols, the company addresses critical vulnerabilities in high-traffic environments, including hospitals, hospitality venues, and large-scale commercial facilities. Their business model leverages both organic innovation and strategic asset acquisition to maintain a competitive edge in the rapidly evolving infection control market. As the demand for automated, non-chemical sanitation solutions grows, Applied UV Inc remains positioned as a key provider of infrastructure-grade health technology.
How much funding has Applied UV Inc raised?
Applied UV Inc has raised a total of $24.1M across 3 funding rounds:
Stock Offering
$7.1M
Stock Offering
$12M
Debt
$5M
Stock Issuance/Offering (2021): $7.1M, investors not publicly disclosed
Stock Issuance/Offering (2021): $12M, investors not publicly disclosed
Debt (2022): $5M, investors not publicly disclosed
Key Investors in Applied UV Inc
Undisclosed Institutional Partner
An undisclosed institutional investor focusing on long-term capital appreciation within the healthcare technology and industrial safety sectors.
Undisclosed Strategic Backer
A strategic investment entity specializing in early-to-growth stage funding for companies developing critical infrastructure and public health solutions.
Undisclosed Private Investor
A private investment group providing flexible financing solutions to support the operational scaling of high-growth technology firms.
What's next for Applied UV Inc?
With the recent deployment of $5M, Applied UV Inc is expected to accelerate its go-to-market strategy and enhance its research and development pipeline. The company is likely to prioritize the integration of its acquired technologies into broader enterprise ecosystems, aiming to capture a larger share of the institutional sanitation market. Future growth will likely hinge on the successful scaling of its commercial operations and the continued validation of its disinfection efficacy in real-world settings. By maintaining a disciplined approach to capital allocation, the firm is well-positioned to transition from a technology developer to a dominant force in the global infection prevention landscape.
See full Applied UV Inc company page
